Calcinase Tablet (Calidinohexanase)

Adult dose

Administer 30~150I.U. per day orally in 3 divided doses. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used in patients with bleeding, such as just after a cerebral hemorrhage. Additionally, this medication contains lactose, so it should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption. This medication contains the pigment Yellow No. 5, so patients who are allergic or hypersensitive to this ingredient should use it with caution. During use, allergic reactions such as skin rashes or itching may occur, so if such symptoms appear, use should be stopped immediately. Also, gastrointestinal symptoms such as palpitations, nausea, vomiting, appetite loss, abdominal pain, diarrhea, and constipation may rarely occur. Occasionally, one may experience fever, headache, drowsiness, and a feeling of lethargy. Elderly patients may have decreased physical function, so when using this medication, it is necessary to reduce the dosage or administer it more carefully.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be kept between 1 degree and 30 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication for a longer time.

Appearance

Orange round enteric-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle